3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
INDUSTRY
5
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
7241
Neoplasms
4538
Prostatic Neoplasms
3489
Colorectal Neoplasms
2939
Carcinoma, Non-Small-Cell Lung
2829
Lung Neoplasms
2546
Leukemia, Myeloid, Acute
1982
Pancreatic Neoplasms
1873
Multiple Myeloma
1810
Carcinoma, Hepatocellular
1732
Neoplasm Metastasis
1585
Stomach Neoplasms
1501
Lymphoma
1456
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1435
Head and Neck Neoplasms
1434
Brain Neoplasms
1370
Melanoma
1346
Ovarian Neoplasms
1342
Leukemia
1303
Rectal Neoplasms
1270
Recurrence
1254
Colonic Neoplasms
1204
Glioblastoma
1137
Uterine Cervical Neoplasms
1096
Lymphoma, Non-Hodgkin
1065
Leukemia, Lymphocytic, Chronic, B-Cell
989
Esophageal Neoplasms
965
Lymphoma, Follicular
936
Lymphoma, Large B-Cell, Diffuse
932
Squamous Cell Carcinoma of Head and Neck
921
Interventions
Curcumin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Interventional
×
Lennox Gastaut Syndrome
×
Clear all
NCT03254680
2018-04-30
Turmeric as Treatment in Epilepsy
NYU Langone Health
Phase NA
Withdrawn